High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer.
作者信息
Ward B G, Slevin M L
出版信息
Br Med J (Clin Res Ed). 1985 May 4;290(6478):1351. doi: 10.1136/bmj.290.6478.1351.
Abstract
摘要
相似文献
1
High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer.高剂量顺铂与高剂量环磷酰胺用于晚期上皮性卵巢癌治疗的比较
Br Med J (Clin Res Ed). 1985 May 4;290(6478):1351. doi: 10.1136/bmj.290.6478.1351.
2
High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.高剂量顺铂与高剂量环磷酰胺治疗晚期上皮性卵巢癌（国际妇产科联盟III期和IV期）的比较：北泰晤士合作组报告
Br Med J (Clin Res Ed). 1985 Mar 23;290(6472):889-93. doi: 10.1136/bmj.290.6472.889.
3
A randomized study of high-dose versus low-dose cis-platinum combined with cyclophosphamide in the treatment of advanced ovarian cancer. Hong Kong Ovarian Carcinoma Study Group.
Chemotherapy. 1989;35(3):221-7. doi: 10.1159/000238673.
4
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.
J Clin Oncol. 1997 May;15(5):1938-44. doi: 10.1200/JCO.1997.15.5.1938.
5
6
7
Cyclophosphamide, cisplatin, and abdominal radiation in advanced ovarian cancer.
J Clin Oncol. 1992 Nov;10(11):1820-1. doi: 10.1200/JCO.1992.10.11.1820.
8
Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.西南肿瘤协作组关于卡铂加环磷酰胺与顺铂加环磷酰胺治疗晚期卵巢癌的III期试验结果。
Oncology. 1993 Nov;50 Suppl 2:2-9. doi: 10.1159/000227253.
9
10
Regimens with intraperitoneal cisplatin plus intravenuous cyclophosphamide and intraperitoneal carboplatin plus intravenuous cyclophosphamide are equally effective in second line intraperitoneal chemotherapy for advanced ovarian cancer.顺铂腹腔内给药联合静脉环磷酰胺和顺铂腹腔内给药联合静脉环磷酰胺方案在晚期卵巢癌二线腹腔化疗中同样有效。
Adv Med Sci. 2012 Jun 1;57(1):46-50. doi: 10.2478/v10039-012-0002-1.
本文引用的文献
1
Advanced ovarian cancer: correlation of histologic grade with response to therapy and survival.晚期卵巢癌：组织学分级与治疗反应及生存的相关性
Cancer. 1980 Feb;45(3):572-81. doi: 10.1002/1097-0142(19800201)45:3<572::aid-cncr2820450325>3.0.co;2-3.
2
Influence of cellular DNA content on survival in advanced ovarian cancer.细胞DNA含量对晚期卵巢癌生存率的影响。
Cancer Res. 1984 Jan;44(1):397-400.
3
Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.细胞DNA含量的流式细胞术分析作为交界性恶性卵巢肿瘤诊断的辅助手段。
Pathology. 1984 Jul;16(3):301-6. doi: 10.3109/00313028409068541.
4
Histology of epithelial tumors of the ovary: clinical usefulness and prognostic significance of the histologic classification and grading.
Semin Oncol. 1975 Sep;2(3):191-201.
Zotero 插件